ANXA5 and COVID-19: In the COVID-19 group, 8.0 [6.0–11.0] % of all EVs (which were defined as Anx5+ events in the EV gate as described in Section 4.2) were associated with TF as compared to 4.0 [2.0–5.0] % in healthy donors (Figure 4, right panel).